Computational Modeling of PI3K/AKT and MAPK Signaling Pathways in Melanoma Cancer
Francesco Pappalardo(University of Catania), Massimo Libra(University of Catania), James A. McCubrey(East Carolina University), Santo Motta(Italian Association for Cancer Research), Saverio Candido(University of Catania), Salvatore Cavalieri(University of Catania), Marzio Pennisi(University of Catania), Ferdinando Nicoletti(University of Catania), Giulia Russo(University of Catania)
Cited by 62
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
|Frontiers in Pharmacology|2018|878
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508